| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Amyotrophic lateral sclerosis | 14 | 3 | |
| General health | 9 | 4 | |
| Support immune health | 8 | 6 | |
| Primary lateral sclerosis | 2 | 7 | |
| Brain fog | 1 | 0 |
Side effect severity
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 0 | |
| Moderate | 0 | |
| Mild | 0 | |
| None | 17 |